Skip to main content
. 2021 Feb 1;11:613204. doi: 10.3389/fimmu.2020.613204

Table 1.

Roles of CD8+NK1.1+/CD8+CD161+ Cells in Infection and Immunity.

Species T cell subset Disease/Model Mechanism of action Reference
Viral/parasitic infections
Murine CD8+NK1.1+ Influenza infection 10% of the lung CD8+T cells upregulate NK cell receptor NK1.1+ upon infection and offer protection Kambayashi et al. (11)
Influenza infection Protection by Tc17 effector cells against influenza infection is IFN-γ dependent and accompanied by greater neutrophil influx into the lung Hamada et al. (23)
LCMV infection CD8+NK1.1+ T cells escape TGF-beta control, resulting in delayed contraction and apoptosis and early pathogen response Ruiz et al. (54)
Listeria infection CD8+NK1.1+ T cells offer protection by early antigen independent innate immune responses mediated by IFN-γ production and GzmB expression Seregin et al. (55)
Malaria Increase in the liver cell numbers of CD8+NK1.1+ cells offer protection against liver stage Plasmodium yoelii infection Pied et al. (56)
Malaria Significant increase in splenic antigen experienced, activated CD8+NK1.1+ T cells offer protection against acute Plasmodium chabaudi infection Muxel et al. (57)
Human CD8+CD161+ Bacterial infections Enhanced migration and enrichment of IFN-γ secreting MAIT cells at the sites of infection helps clear the pathogen Le Bourhis et al. (19)
EBV/CMV/influenza Self renewing, antigen specific CD8+CD161high memory cells express anti-apoptotic molecules and survive cytotoxic chemotherapy Turtle et al. (3)
HCV/HBV Antigen specific CD8+CD161+ T cells secrete pro-inflammatory cytokines IFN-γ and TNF-α and offer protection Northfield et al. (4)
Viral infection CD8+CD161+ T cells markedly enriched in the liver coexpressed IL-17 with high levels of IFN-γ and/or IL-22 and offer protection against viral infections. Billerbeck et al. (7)
Tumor biology
Murine CD8+NK1.1+ Leukemia/lymphoma Expansion of cytolytic NKT cells producing IFN-γ limits GVHD in leukemia Baker et al., Verneris et al. (68, 69)
Melanoma NKT like CD8+NK1.1+ T cells exert cytotoxicity against tumor cells and MDSCs, inhibit metastasis and improve survival Li et al. (34)
Murine Pancreatic ductal Adenocarcinoma Adoptive transfer of antigen experienced CD8+NK1.1 cells offer anti-tumor protection Konduri et al. (53)
Pancreatic Cancer Anti-tumor effects of NKT cells is dependent upon tumor associated macrophage mediated TH1 adaptive immune response Janakiram et al. (70)
Human CD8+CD161+ Head and Neck cancer In HNSCC, immune evasion is mediated by down regulation of CD161 on Th17 cells in peripheral blood, primary tumor tissue, and lymph nodes Kesselring et al. (41)
HPV-Oropharyngeal squamous cell cancer Antigen specific CD161+ T cells produce IL-17 and IFN-γ in the type-1 oriented tumor microenvironment resulting in reduced tumor burden and improved overall survival Welters et al. (75)
Hepatocellular Carcinoma Co-expression of CD161 and IL-7R helps maintain proliferation of CD8+PD-1+ T cells partly through enhanced expression of IL-2, TNF-α, and perforin resulting in better prognosis Li et al. (76)
Lymphoma In transplant setting, host NKT cells prevented lethal GVHD while perforin producing CD8+ T cells offered graft antitumor activity Pillai et al. (77)
Lymphoma IL21 promoted expansion of Th1 skewed cytotoxic CAR NKT cells offering protection Ngai et al. (78)
Multiple tumors KLRB1, the gene encodign CD161 is associated with favorable outcomes against multiple tumor models Gentles et al., Braud et al. (72, 73)
Multiple tumors The potential immunoregulatory role of CD4+ CD161+ cells is mediated through soluble factors, high IL-10, IL-4, and TGF-β resulting in disease progression Iliopoulou et al. (79)
NSCLC Tumor infiltrating CD8+CD161+ interact with LLT1 expressing germinal center B cells within TME resulting in improved survival Braud et al. (73)
Pediatric Leukemia iNKT cell subsets in hHSCT recipients contribute to the maintenance of the remission state, possibly through the provision of antitumor cytokine IFN-γ. de Lalla et al. (80)
Autoimmunity
Human CD8+CD161+ Autoimmune diseases IL-17 producing Th17 cells mediate tissue inflammation and autoimmune progression in gut, joints, and brain by secreting inflammatory cytokines like IL-23 Cosmi et al., Kleinschek et al., Lock et al., Tzartos et al., Annibali et al. (6064)
Systemic Lupus Erythematosus Abnormalities in the frequencies and levels of CD161 expression on CD8+ T cells and NKT cells correlate to the pathogenesis of SLE. Park et al. (67)